TVTX
Travere Therapeutics Inc
56.90$
+0.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -437.1% | – | – | – | – | – | – | – | |
| – | +148.0% | +20.5% | +10.3% | +4.9% | +9.3% | +20.4% | -48.1% | +62.6% | +86.0% | +13.0% | +39.5% | |
| – | +62.9% | +12.4% | -7.7% | -26.4% | +6.7% | +11.9% | +25.2% | +29.0% | +16.0% | -16.6% | +21.6% | |
| – | – | – | – | +0.4% | +22.7% | +112.9% | -80.3% | +79.3% | – | – | – | |
| – | -192.5% | – | -30.3% | +190.2% | -76.3% | -1,092.5% | – | -98.9% | -3,011.4% | – | – | |
| – | +77.3% | +69.6% | +17.5% | +40.6% | -21.0% | +670.0% | -79.8% | +17.5% | +46.6% | +143.4% | -42.5% | |
| – | +116.3% | – | +339.7% | -545.8% | – | -408.7% | +124.4% | -76.3% | – | +78.1% | -71.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -57.6% | – | – | – | – | – | +3.2% | +1,183.5% | – | – | – | |
| – | – | – | – | +0.0% | -55.5% | +0.0% | +0.0% | -9.4% | -100.0% | – | – | |
| – | +5.7% | -105.7% | – | +4,158.3% | -100.9% | – | +81.4% | -49.3% | +86.1% | -36.3% | -124.0% | |
| – | +60.6% | -83.7% | +1,726.5% | -94.0% | -1,262.3% | – | +262.6% | -228.5% | – | – | +9,510.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.